IRIS
MONTORSI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 45.069
EU - Europa 41.849
NA - Nord America 30.662
SA - Sud America 12.458
AF - Africa 1.097
OC - Oceania 125
Continente sconosciuto - Info sul continente non disponibili 26
AN - Antartide 1
Totale 131.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.148
RU - Federazione Russa 24.012
SG - Singapore 16.688
CN - Cina 12.491
BR - Brasile 10.259
HK - Hong Kong 6.249
IT - Italia 4.997
SE - Svezia 4.505
VN - Vietnam 4.247
FR - Francia 2.296
BD - Bangladesh 1.342
DE - Germania 1.303
IN - India 970
AR - Argentina 871
GB - Regno Unito 830
RO - Romania 827
FI - Finlandia 730
CA - Canada 674
ID - Indonesia 555
NL - Olanda 478
MX - Messico 451
EC - Ecuador 389
IQ - Iraq 371
IE - Irlanda 353
JP - Giappone 334
ZA - Sudafrica 305
TR - Turchia 303
ES - Italia 284
CO - Colombia 260
PL - Polonia 248
AT - Austria 231
UA - Ucraina 185
PK - Pakistan 174
PY - Paraguay 171
VE - Venezuela 149
CL - Cile 145
MA - Marocco 145
MY - Malesia 136
UZ - Uzbekistan 131
EG - Egitto 122
SA - Arabia Saudita 119
NP - Nepal 103
TN - Tunisia 99
AU - Australia 97
KE - Kenya 91
PH - Filippine 89
PE - Perù 87
AE - Emirati Arabi Uniti 82
IR - Iran 75
UY - Uruguay 74
LT - Lituania 71
DZ - Algeria 68
JO - Giordania 67
NG - Nigeria 63
DO - Repubblica Dominicana 61
JM - Giamaica 61
AZ - Azerbaigian 60
CH - Svizzera 58
BE - Belgio 53
KZ - Kazakistan 52
IL - Israele 51
KR - Corea 45
CR - Costa Rica 42
TW - Taiwan 41
BO - Bolivia 37
HN - Honduras 37
TH - Thailandia 37
TT - Trinidad e Tobago 37
CZ - Repubblica Ceca 35
GR - Grecia 34
LB - Libano 33
BG - Bulgaria 32
AL - Albania 31
OM - Oman 29
RS - Serbia 29
GT - Guatemala 28
PT - Portogallo 28
SN - Senegal 28
SV - El Salvador 28
BH - Bahrain 26
ET - Etiopia 25
KW - Kuwait 25
NO - Norvegia 25
PS - Palestinian Territory 25
MD - Moldavia 24
BY - Bielorussia 21
PA - Panama 21
BA - Bosnia-Erzegovina 20
BB - Barbados 20
DK - Danimarca 19
TZ - Tanzania 18
HU - Ungheria 17
NZ - Nuova Zelanda 16
SY - Repubblica araba siriana 16
CY - Cipro 15
KG - Kirghizistan 15
XK - ???statistics.table.value.countryCode.XK??? 15
CI - Costa d'Avorio 14
LV - Lettonia 14
SC - Seychelles 14
Totale 130.956
Salva come PNG Salva come JPEG
Città #
Singapore 6.770
Hong Kong 6.177
Moscow 5.745
Dallas 5.191
San Jose 4.120
Ashburn 3.756
Shanghai 2.291
Hefei 2.278
Lawrence 2.119
Princeton 2.113
Lauterbourg 1.940
Ho Chi Minh City 1.575
New York 1.231
Beijing 1.128
Milan 995
Hanoi 909
São Paulo 803
Los Angeles 724
Helsinki 541
Santa Clara 466
Orem 384
Rome 372
Rio de Janeiro 349
Dublin 345
Munich 296
Boardman 287
Nuremberg 238
Belo Horizonte 218
Montreal 213
Brooklyn 207
Chennai 199
Denver 194
Brasília 193
Da Nang 193
Warsaw 190
Tokyo 186
Atlanta 175
Guangzhou 173
Haiphong 170
Pune 170
Chicago 169
Curitiba 158
Johannesburg 152
Houston 148
Phoenix 146
Frankfurt am Main 145
San Francisco 144
London 143
Porto Alegre 141
Naples 140
Turin 135
Seattle 133
Mexico City 132
Turku 132
Toronto 128
Baghdad 127
Quito 126
Campinas 124
The Dalles 124
Guayaquil 121
Washington 116
Manchester 114
Mumbai 114
Tashkent 114
Biên Hòa 113
Tianjin 112
Stockholm 111
Vienna 110
Bologna 108
Boston 105
Columbus 105
Amsterdam 103
Buffalo 102
Guarulhos 101
Salvador 101
Council Bluffs 99
Poplar 99
Hangzhou 98
Thái Bình 97
Florence 94
Hải Dương 93
Jakarta 93
Ribeirão Preto 85
Dhaka 84
Paris 78
Goiânia 77
Kuala Lumpur 76
Manaus 76
Istanbul 74
Recife 74
Fortaleza 73
Shenzhen 73
Ankara 69
Buenos Aires 69
Caxias do Sul 68
Erbil 67
Nairobi 67
Ninh Bình 65
Santo André 64
Sumaré 62
Totale 61.995
Salva come PNG Salva come JPEG
Nome #
Worldwide Temporal Trends in Penile Length: A Systematic Review and Meta-Analysis 2.595
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.890
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.429
Benign Prostatic Hyperplasia and Its Aetiologies 477
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers 401
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer 385
High serum alpha-fetoprotein levels in primary infertile men 374
Women's sexual dysfunction: a pathophysiological review 312
Nasal congestion after visual sexual stimulation with and without sildenafil (Viagra (R)): a randomized placebo-controlled study 237
Sildenafil taken at bedtime significantly increases nocturnal erections: Results of a placebo-controlled study 225
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 224
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 224
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 221
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 216
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 209
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 206
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 190
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 187
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 184
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 180
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases 173
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 172
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 169
Organic vs. Psychogenic? The Manichean Diagnosis in Sexual Medicine 169
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 160
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 158
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 157
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 155
Long-term safety and tolerability of thdalafil in the treatment of erectile dysfunction 151
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 148
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 148
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 147
A mechanistic insight into the anti-metastatic role of the prostate specific antigen 147
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 145
Normal sperm parameters per se do not reliably account for fertility: A case–control study in the real-life setting 144
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 144
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 143
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 142
The Importance of Discordant Follicle Stimulating Hormone and Inhibin B Levels in Primary Infertile Men: Findings from a Cross-Sectional Study 140
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 140
120-MONTH MEDIAN FOLLOW-UP OF INTRACAVERNOUS INJECTION THERAPY FOR ERECTILE DYSFUNCTION 140
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 138
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 138
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 138
A global approach to improving penile cancer care 136
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 135
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 135
Hyperestrogenism is associated with sexual function impairment in men-findings from a cross-sectional, real-life study 134
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 134
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 134
Does sildenafil enhance quality of nocturnal erections in healthy young men? A NPT-RigiScan (TM) study 133
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease 132
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy 132
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 132
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 131
Can We Rely Solely on the International Prostate Symptoms Score to Investigate Storage Symptoms in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement? Findings from a Cross-sectional Study 131
How to Select the Optimal Candidates for Renal Mass Biopsy 131
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis 130
A CRITICAL APPRAISAL OF THE ABILITY OF BODY MASS INDEX (BMI) TO PREDICT HIGH-GRADE PROSTATE CANCER (PCA) 130
Medications mostly associated with priapism events: assessment of the 2015-2020 Food and Drug Administration (FDA) pharmacovigilance database entries 129
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 129
A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies 129
Clinical parameters associated with altered sperm DNA fragmentation index among primary infertile men: Findings from a real-life cross-sectional study 129
ROBOT-ASSISTED RADICAL PROSTATECTOMY IS ASSOCIATED WITH FASTER AND GREATER RECOVERY FROM ORGASM ASSOCIATED INCONTINENCE 129
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 129
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 128
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 128
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 128
Gold nanorod–assisted theranostic solution for nonvisible residual disease in bladder cancer 127
Role of Follicle-stimulating Hormone, Inhibin B, and Anti-Müllerian Hormone in Predicting Sperm Retrieval from Men with Nonobstructive Azoospermia Undergoing Microdissection Testicular Sperm Extraction: A Systematic Review and Meta-analysis 127
Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? 127
Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up 127
4-DRUG INTRACAVERNOUS THERAPY FOR IMPOTENCE DUE TO CORPOREAL VENOOCCLUSIVE DYSFUNCTION 127
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 126
Prediction of Functional Outcomes After Nerve-Sparing Radical Prostatectomy: Results of Conditional Survival Analyses 126
[In Process Citation]. FT Doit-on porter des lunettes protectrices lors de l'utilisation du laser Holmium:YAG lors des procedures endourologiques? Etude chez un modele animal. 126
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study 126
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 126
Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve 125
Haemospermia in the Real- Life Setting: A New High-Risk Stratification 125
Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. 125
Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age 125
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 125
Rates and predictors of postoperative complications after Holmium laser enucleation of the prostate (HoLEP) at a high-volume center 125
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 124
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 124
[Management of erectile dysfunction in patients with preexisting cardiovascular disease]. FT Disfunzione erettile nel paziente cardiopatico: diagnosi e raccomandazioni terapeutiche. 124
The effect of intracorporeal injection plus genital and audiovisual sexual stimulation versus second injection on penile color Doppler sonography parameters 124
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 123
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 123
30-DAY MORTALITY AFTER RADICAL PROSTATECTOMY IN OVER 9000 PATIENTS: VALIDATION OF A PREDICTIVE NOMOGRAM 123
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 123
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 122
Low Birth Weight is Associated with Sperm DNA Fragmentation and Assisted Reproductive Technology Outcomes in Primary Infertile Men: Results of a Cross-Sectional Study 122
Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study 122
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 121
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 121
Correlation among isolated teratozoospermia, sperm DNA fragmentation and markers of systemic inflammation in primary infertile men 121
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 120
Kidney function impairment in men with primary infertility: A case-control analysis 120
Totale 21.092
Salva come PNG Salva come JPEG
Categoria #
all - tutte 897.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 897.978
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/20221.273 1 58 30 577 61 65 90 75 42 69 55 150
2022/202310.126 4.873 1.738 601 119 68 1.013 434 606 272 96 151 155
2023/20245.160 235 279 399 356 413 922 292 508 90 383 562 721
2024/202529.158 4.249 726 542 672 691 2.350 4.169 2.213 5.247 4.330 1.813 2.156
2025/202686.088 5.690 7.391 7.341 12.527 5.552 1.933 7.576 5.681 21.004 4.567 4.311 2.515
Totale 132.562